INTRODUCTION
============

The total number of different molecules comprising the human and mouse transcriptomes far exceeds the predicted number of genes. A single gene may give rise to multiple transcript variants that encode identical or different proteins, and the decision to express certain transcripts but not others is spatially and temporally coordinated.

Although gene expression is influenced by tissue- and developmental stage-specific transcription factors, epigenetic mechanisms also play an important role. For example, DNA methylation and a subset of histone modifications such as H3K27me3 and H3K9me3 are typically associated with transcriptional repression when they are abundant at promoters. Genes that are subject to genomic imprinting are a special case of this type of epigenetic regulation of transcription. Allele-specific DNA methylation established during gametogenesis at imprinting control regions regulates the parent-of-origin specific expression of imprinted genes ([@gks654-B1]).

In part, transcript diversity can be accounted for by differential promoter usage, and the role of epigenetic mechanisms in this process is well established. For example, at least two promoters are embedded within the gene body of *Shank3*, in addition to the canonical 5′ *Shank3* promoter ([@gks654-B2]). DNA methylation at these internal promoters is inversely correlated with internal transcription initiation, and differs between tissues, providing a mechanism for regulating tissue-specific promoter use. Alternative splicing is another key mechanism for generating transcript diversity, with ∼95% of human multi-exonic genes estimated to produce at least two transcript isoforms by differential exon inclusion ([@gks654-B3]). Epigenetic mechanisms have recently been suggested to regulate the tissue-specific and mutually exclusive use of exons IIIb and IIIc in transcripts of the human *FGFR2* gene. Alternative splicing of these exons is associated with differential enrichment for specific histone H3 modifications between tissues ([@gks654-B4]). Modulating the levels of these histone modifications results in the loss of tissue-specific splicing.

A third mechanism for generating transcript diversity is the use of alternative polyadenylation \[poly(A)\] sites. Little is known about the regulatory mechanisms that control this process, although the cell-specific activity of *trans*-acting RNA processing factors is thought to play a role ([@gks654-B5; @gks654-B6; @gks654-B7]). The possibility that epigenetic modifications could act *in cis* to regulate this process is supported by studies of an imprinted gene locus in the mouse. The locus comprises the *Mcts2* retrogene that is situated in an intron of the multi-exonic 'host' gene *H13* ([@gks654-B8],[@gks654-B9]). Retrogenes are functional genes resulting from retrotransposition of an mRNA molecule into the genome ([@gks654-B10]). The retrogene *Mcts2* is imprinted, being silenced on the maternally inherited chromosome through methylation of its promoter, which is situated 200 bp downstream of an internal *H13* poly(A) site ([@gks654-B9]). When the *Mcts2* promoter is unmethylated and active, *H13* transcripts utilize the upstream poly(A) site, whereas the methylated and inactive allele allows transcription of *H13* to proceed to a poly(A) site situated 10 kb downstream. These observations cannot be explained by cell type-specific RNA processing factors operating *in trans*, as both alleles would be exposed to the same complement of diffusible molecules, and hence epigenetic modifications operating *in cis* must be the determining factor. This could be mediated through the binding of methylation-sensitive polyadenylation factors, or through transcriptional interference from transcripts initiating at the *Mcts2* promoter.

In this report, we characterize in detail another locus at which an imprinted retrogene, *Nap1l5*, is positioned within an intron of a host gene, *Herc3*, that utilizes multiple poly(A) sites. Full-length *Herc3* transcripts that utilize a downstream poly(A) site encode a probable E3 ubiquitin ligase that targets proteins for proteasomal-mediated degradation ([@gks654-B11]). The gene is broadly expressed and demonstrates a subcellular localization consistent with a role in vesicular trafficking ([@gks654-B11],[@gks654-B12]). The Nap1l5 protein is also incompletely characterized, but is likely to associate with Nap1l2 which is a chromatin-modifying protein critical for neuronal development ([@gks654-B13],[@gks654-B14]). Consistent with this, *Nap1l5* is most abundantly expressed in neural tissues ([@gks654-B12],[@gks654-B15]).

The *Nap1l5* promoter is associated with a germline differentially methylated region (gDMR), being unmethylated on the paternally derived chromosome and heavily methylated on the maternally derived chromosome. We demonstrate that polyadenylation sites of *Herc3* are utilized in an allele-specific manner. A subset of transcripts arising from the paternally inherited allele, from which *Nap1l5* is expressed, use internal poly(A) sites upstream of *Nap1l5*, whereas a downstream poly(A) site is preferentially used on the maternally inherited allele, on which *Nap1l5* is silent. Ablation of *Nap1l5* promoter methylation on the maternally inherited allele causes biallelic *Nap1l5* expression, and increased use of an internal *Herc3* poly(A) site, providing a clear example of epigenetic control of poly(A) site choice. Although in this study we do not conclusively determine the mechanism responsible for mediating this effect, we demonstrate that the abundance of *Herc3* transcripts using an internal poly(A) site is not correlated to overall *Herc3* transcription levels, but is closely correlated with the level of *Nap1l5* transcription *in vivo*, supporting a role for transcriptional interference.

MATERIALS AND METHODS
=====================

Tissue sources
--------------

Mouse strains used for allele-specific assays were C57Bl6 (Bl6) and *Mus musculus castaneus* (cast). RNA from *Dnmt3L*^−/+^ e8.5 embryos and wild-type littermates was a kind gift of Deborah Bourc\'his.

RNA isolation and 3′ rapid amplification of cDNA ends (RACE)
------------------------------------------------------------

Total RNA was purified from a whole Day 1 mouse brain using the Qiagen RNeasy Mini kit. One microgram was used to synthesize 3′ RACE-ready cDNA using the SMARTer RACE kit (Clontech). RACE was performed using the Advantage 2 PCR kit (Clontech) and touchdown PCR, as described in the associated manual, on a MJ Research PTC-200 DNA Engine thermal cycler. 3′ RACE primers were designed to *Herc3* exons 1c, 3, 4, 5, 22 and 23b. Primer sequences are presented in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gks654/DC1). Amplicons were purified from agarose gels (Qiagen MinElute kit) and cloned into the pGEM T-Easy vector (Promega) for sequencing. Multiple clones of each amplicon were sequenced using Big Dye v3.1 (ABI) sequencing technology. Sequence data were manipulated in Sequencher.

Northern blotting
-----------------

Probe A, spanning *Herc3* exons 2--5, was amplified from brain cDNA using Herc3-F5 and Herc3-R5 ([Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gks654/DC1)) and cloned into the pGEM T-Easy vector. The 0.4 kb fragment was isolated by *Eco*RI digestion, gel-purified and used to generate \[α-^32^P\]dCTP-labeled probe with a High Prime DNA labeling kit (Roche) according to the associated manual. Total RNA from 2-week mouse brain was challenged with the probe as described previously ([@gks654-B16]). The relative abundance of *Herc3a* and *Herc3b* was assessed using ImageJ (<http://rsbweb.nih.gov/ij/>).

Allele-specific assays
----------------------

RNA was purified from whole brain, heart and lung of Bl6/cast inter-subspecies hybrid Day 1 neonates as above. RNA was treated with DNase I using DNA-free (Ambion) according to the manufacturer's instructions. cDNA was synthesized from 1 µg RNA using the SuperScript first strand synthesis kit (Invitrogen). Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed with ABgene ReddyMix and primers specific to each transcript, using multiple cycles of 94°C for 30 s, 55°C for 30 s and 72°C for 30 s. For *Herc3a*, 28 PCR cycles were used; for *Herc3b* transcripts using the *Herc3b1* and *Herc3b2* poly(A) sites and *Herc3c* transcripts, 35 cycles; and for *Nap1l5*, 30 cycles. Primers were as follows. *Herc3a*: Herc3-F1 in exon 20 and Herc3-R1 in exon 25. *Herc3b1*: Herc3-F2 in exon 20 and Herc3-R2 in exon 23b. *Herc3b2*: Herc3-F3 in exon 22 and Herc3-R3 in exon 23c. *Herc3c*: Herc3-F4 in exon 1c and Herc3-R4 in exon 25. Primer sequences are presented in [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gks654/DC1). Amplicons were sequenced over single nucleotide polymorphisms (SNPs) identified from the Sanger Mouse Genomes Project ([@gks654-B17],[@gks654-B18]). SNPs were confirmed by amplifying from genomic DNA isolated from Bl6, cast and B × C animals; primer sequences and reaction conditions for these amplifications are available on request.

Pyrosequencing
--------------

RNA was isolated from whole brains and hearts of three B × C and three C × B inter-subspecies hybrid Day 1 neonates, and cDNA was synthesized, as discussed earlier. Pyrosequencing assays were designed for the *Herc3a* and *Herc3c* transcripts using PyroMark Assay Design 2.0 software (Qiagen). Primer sequences, as well as details on which primers were biotinylated, are provided in [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gks654/DC1). For each transcript, 'pyro F1' and 'pyro R1' were used for PCR amplification, and 'pyro S1' for sequencing. The SNPs quantified in the assays were the same SNPs used in the allele-specific assays described earlier. PCR was performed using ABgene ReddyMix and the same conditions as earlier, except that 30 amplification cycles were utilized for both the *Herc3a* and *Herc3c* transcripts. Reactions were prepared for analysis by using the PyroMark Q96 Vacuum Prep Workstation (Qiagen) according to the manufacturer's instructions, and pyrosequencing was conducted on a PyroMark Q96 MD machine (Qiagen).

[Figure 2](#gks654-F2){ref-type="fig"}B shows the mean of data from three biological replicates for *Herc3a*, and from two biological replicates for *Herc3c*. For one B × C and one C × B sample, allele quantification of *Herc3c* expression could not be determined with accuracy because the peaks were close to background levels, although both samples showed a bias consistent with the expected direction of imprinting (87.4 and 91.8% paternal allele expression in the B × C and C × B samples, respectively).

qRT-PCR
-------

Custom TaqMan expression assays for amplification of *Herc3a*, *Herc3b* \[using the *Herc3b1* poly(A) site\], *Herc3c* and *Nap1l5* were ordered from ABI. The *H13a* assay has been described previously ([@gks654-B8]). cDNA was synthesized from 1 µg DNase I-treated total RNA isolated from pooled e8.5 wild-type or *Dnmt3L*^−/+^ embryos, using the method described earlier. For embryo qPCR, confidence intervals in [Figure 3](#gks654-F3){ref-type="fig"}B represent three technical replicate reactions for each transcript and template, normalized to expression of β-actin (*Actb*). Reactions were prepared, run and analysed as described previously ([@gks654-B16]).

To compare expression of *Nap1l5* and *Herc3b* in different tissues, cDNA was synthesized from 1 µg DNase I-treated RNA isolated from whole brains, hearts and lungs of five newborn (Day 1) B × C littermates. For each sample, reactions were performed in triplicate and normalized to expression of *Actb*.

Protein domain and open reading frame prediction
------------------------------------------------

*Herc3* transcript sequences were submitted to the EMBL SMART Tool ([@gks654-B19],[@gks654-B20]) for domain prediction analysis. The open reading frame (ORF) of transcripts utilizing the *Herc3b2* poly(A) site was predicted using NCBI ORF Finder (<http://www.ncbi.nlm.nih.gov/projects/gorf/>). The ORFs of *Herc3a*, *Herc3c* and transcripts utilizing the *Herc3b1* poly(A) site predicted by this program were consistent with the UCSC Known Genes annotation ([@gks654-B21]).

RESULTS
=======

Locus organization and alternative poly(A) sites
------------------------------------------------

To characterize the locus fully, we focussed initially on brain where both *Nap1l5* and *Herc3* are abundantly expressed ([@gks654-B12]). Full-length *Herc3* transcripts (*Herc3a*) consist of 25 exons, of which all except the first exon contribute to the ORF ([Figure 1](#gks654-F1){ref-type="fig"}A). The UCSC Known Genes annotation ([@gks654-B21]) includes a truncated transcript isoform of *Herc3* utilizing an alternative final exon (exon 23b) and internal poly(A) site. 3′ RACE (rapid amplification of cDNA ends) performed on whole brain cDNA confirms this annotation and we refer to this shorter isoform as *Herc3b*. Using 3′ RACE and RT-PCR, we identify an additional internal poly(A) site that is coupled to an alternative splicing event from exon 22 onto exon 23c ([Figure 1](#gks654-F1){ref-type="fig"}A and [Supplementary Figure 1A--C](http://nar.oxfordjournals.org/cgi/content/full/gks654/DC1)). We differentiate these internal poly(A) sites by calling them *Herc3b1* and *Herc3b2*. Northern blotting with a probe complementary to exons 2--5 detects mRNA species consistent with the predicted sizes of transcripts utilizing the *Herc3a* and *Herc3b1* poly(A) sites, but not the *Herc3b2* poly(A) site, probably reflecting the low abundance of transcripts using this poly(A) site ([Figure 1](#gks654-F1){ref-type="fig"}B). Processed *Herc3a* transcripts are ∼50× more abundant than *Herc3b* transcripts in whole brain. All *Herc3* transcripts utilize canonical poly(A) signals: either AAUAAA (*Herc3a* and *Herc3b2*) or AUUAAA (*Herc3b1*) ([Supplementary Figure 1D](http://nar.oxfordjournals.org/cgi/content/full/gks654/DC1) and data not shown). Figure 1.Transcription at the *Herc3*/*Nap1l5* locus. (**A**) Transcripts at the locus, as determined by 3′ RACE, RT-PCR, northern blotting and expressed sequence tag data. Exons (numbered) are shown as non-coding (short vertical lines or solid boxes) or coding (tall vertical lines). Splicing events are illustrated by dashed lines. The direction of transcription is illustrated by horizontal arrows and polyadenylation sites by *A*~n~. The gray bar represents the gDMR at the *Nap1l5* promoter, that is methylated in oocytes (filled circles) and unmethylated in sperm (open circles). The position of probe A used in northern blotting is shown by a black bar. The diagram is not drawn to scale. (**B**) Northern blot of 2-week brain RNA using probe A, illustrating the relative abundance of transcripts utilizing the *Herc3a* and *Herc3b1* poly(A) sites.

According to the UCSC Known Genes annotation, *Herc3b* utilizes a different initiation exon (exon 1b) to that utilized for *Herc3a* transcripts (exon 1a). However, by long-range PCR, we demonstrate that transcripts initiating at exon 1b can produce *Herc3b* transcripts or form full-length *Herc3a* transcripts ([Figure 1](#gks654-F1){ref-type="fig"}A and data not shown), suggesting that the choice of poly(A) site is not dependent on the initiation exon used.

An additional *Herc3* transcript, annotated as distinct by UCSC Known Genes, initiates from an alternative promoter positioned within intron 22 and splices from a unique first exon (exon 1c) onto exon 23a, producing a transcript of 2.2 kb referred to as *Herc3c*. The annotated transcription start site of the retrogene *Nap1l5* is 306 bp upstream of the annotated transcription start site of *Herc3c*. However, there are expressed sequence tags that bridge this gap. *Nap1l5* is transcribed in an anti-sense orientation to its host, and thus these data are consistent with a bidirectional promoter that is shared between *Nap1l5* and *Herc3c*. *Nap1l5* is monoexonic, like many products of retrotransposition, and its poly(A) site is downstream of *Herc3* exon 23c ([Figure 1](#gks654-F1){ref-type="fig"}A).

*Herc3* poly(A) sites are utilized in an imprinted manner
---------------------------------------------------------

*Nap1l5* was identified as an imprinted gene in a genome-wide screen for maternal methylation ([@gks654-B15]), and we have previously shown that a promoter-associated CpG island (CGI) is differentially methylated in sperm and oocytes ([@gks654-B9]). *Nap1l5* shares a number of features with the retrogene *Mcts2*, including a promoter-associated DMR and a position within an intron of a host gene that exhibits both upstream and downstream poly(A) sites. The host gene of *Mcts2*, *H13*, utilizes poly(A) sites in an imprinted manner. Given these similarities between the *Mcts2* and *Nap1l5* retrogenes, we examined each *Herc3* transcript for imprinted expression. Indeed, imprinting of *Herc3* has previously been suggested by RNA-seq experiments conducted on brain cDNA of inter-subspecies hybrid mice ([@gks654-B22]). In that study, exonic SNPs between the two parental strains (C57Bl6 \[Bl6\] and *Mus musculus castaneus* \[cast\]) indicated that most *Herc3* exons are expressed from the maternally derived allele. However, exon 23b, specific to *Herc3b*, showed paternal allele-specific expression. To examine the imprinted status of each of the *Herc3* transcripts independently, we designed primers specific to each variant. We amplified from whole neonatal brain cDNA from inter-subspecies hybrid mice and sequenced across SNPs.

In brain, full-length *Herc3a* transcripts are preferentially expressed from the maternally inherited allele, but there is a clear contribution from the paternally derived copy ([Figure 2](#gks654-F2){ref-type="fig"}A). Conversely, transcripts utilizing the internal *Herc3b1* and *Herc3b2* poly(A) sites exhibit exclusive expression from the paternally inherited allele. *Herc3c* transcripts are also paternally expressed, consistent with bidirectional transcription initiation from the unmethylated allele of the *Nap1l5* CGI promoter. Figure 2.Allele-specific use of poly(A) sites. (**A**) Primer pairs unique to each of the *Herc3* transcript variants were used in RT-PCR on RNA isolated from whole brains of inter-subspecies mouse hybrids (Bl6 \[B\] and cast \[C\]). Amplicons were sequenced across SNPs to determine parent-of-origin specific expression. The SNP is the centre nucleotide of each trace. In each cross, the maternal strain is presented first. Performing the experiment on the reciprocal cross confirms true imprinted expression, rather than a preference for expression from either the Bl6 or cast alleles. The relevant genomic DNA (gDNA) sequences of the parental strains and of a B × C hybrid are shown at the top of the figure. The allele on which the poly(A) site associated with each transcript is utilized is indicated below each panel of traces (maternal bias or paternal). Some of the base calls are presented as a mirror image; this reflects the sequencing of some amplicons in the reverse orientation and does not influence the interpretation of the data. (**B**) Quantification of allele-specific expression of *Herc3a* and *Herc3c* using pyrosequencing over Bl6/cast SNPs (see Materials and Methods for details). In neonatal brain, *Herc3a* is expressed with a bias from the maternal allele (62:38 maternal:paternal ratio) but is expressed approximately equally from the two alleles in heart (52:48 maternal:paternal ratio). This is the case for samples from both B × C and C × B intercrosses. As a control, *Herc3c*, shown in (A) to be paternally expressed in brain, shows expression exclusively from the paternally derived allele in C × B brain and \>90% paternal expression in B × C brain, confirming the sensitivity of this approach in determining allele-specific expression. Error bars indicate the standard error of the percent maternal expression values from biological replicates. (**C**) Sequence traces showing that transcripts utilizing the downstream poly(A) site (*Herc3a* transcripts) are derived equally from the two parental alleles in heart and lung.

The biased expression of *Herc3a* from the maternally inherited allele is corroborated by results from pyrosequencing, a technique that permits quantification of allelic expression. In Bl6 × cast (B × C, where the maternal strain is presented first) brain samples, we find that the maternal allele contributes ∼62% of the *Herc3a* mRNA, and this result is reproduced in reciprocal C × B samples, confirming that this bias is due to parent-of-origin rather than a specific sequence ([Figure 2](#gks654-F2){ref-type="fig"}B). As a control, *Herc3c* shows strong paternal allele-specific expression in brain ([Figure 2](#gks654-F2){ref-type="fig"}B).

Together, these assays validate and extend the findings of ([@gks654-B22]), showing complex isoform-specific imprinting at this locus. Given that *Herc3a* and *Herc3b* transcripts initiate at a shared promoter, it is the poly(A) sites that are utilized in an allele-specific manner.

Maternal germline methylation influences *Herc3* poly(A) site choice
--------------------------------------------------------------------

To investigate the importance of DNA methylation at the *Nap1l5* promoter in influencing *Herc3* poly(A) site choice, we took advantage of mice with a mutation in the *Dnmt3L* gene. Female *Dnmt3L*^−/−^ mice produce oocytes lacking maternal germline methylation at imprinting control regions ([@gks654-B23]). During development, embryos from *Dnmt3L*^−/−^ mothers inappropriately either express or repress imprinted genes on both alleles, ultimately resulting in embryonic lethality after e9.5 ([@gks654-B23]). We first confirmed that methylation of the *Nap1l5* promoter CGI is dependent on *Dnmt3L* using published reduced representation bisulfite sequencing data ([@gks654-B24]) ([Figure 3](#gks654-F3){ref-type="fig"}A). Methylation levels of the *Nap1l5* promoter in wild-type germinal vesicle (GV) and metaphase II (MII) oocytes exceed 90%, compared with 4% in sperm, confirming our previous observation of differential methylation in gametes ([@gks654-B9]). In wild-type blastocysts, methylation levels are ∼55%, consistent with differential methylation on the two alleles persisting after fertilization. GV oocytes depleted for *Dnmt3L* are \<5% methylated at the *Nap1l5* promoter, confirming the dependence of this gDMR on Dnmt3L activity. The CGI at the *Herc3a/b* promoter is \<10% methylated in all cell types and stages examined. Figure 3.Methylation and transcription analyses. (**A**) Percentage methylation at the internal *Nap1l5* promoter and the 5′ *Herc3* promoter in gametes and blastocyst (blast.). GV, germinal vesicle oocytes; MII, metaphase II oocytes. GV oocytes derived from females deficient for *Dnmt3L* (3L^−/−^) are hypomethylated at the *Nap1l5* promoter relative to wild-type controls (3L^+/+^). The data are derived from a reduced representation bisulfite sequencing experiment performed in ([@gks654-B24]). (**B**) mRNA abundance determined by qRT-PCR on pooled *Dnmt3L*^−/+^ (3L^−/+^) e8.5 embryos relative to wild-type littermates (3L^+/+^), normalized to *Actb*. The mean values from three technical replicates are presented for each transcript. Error bars indicate the 95% confidence interval. Probability values were calculated using Student's *t* test. (**C**) Relative abundance of *Nap1l5* transcripts in brain, heart and lung. The bottom and top of the box represent the 25th and 75th percentiles, respectively; the internal line represents the median; and the whiskers represent the range of the data. Transcript abundance between the tissues was assessed using one-way analysis of variance. \*\**P* \< 0.01, \*\*\**P* \< 0.001. (**D**,**E**) Relative abundance of *Herc3b* and *Herc3a* transcripts, as for (C). (**F**) Main image: Relationship between *Nap1l5* expression level and use of the *Herc3b1* poly(A) site in brain, heart, lung and wild-type e8.5 embryo. Inset: Association between the natural variation of *Nap1l5* expression and use of the *Herc3b1* poly(A) site in the brains of Day 1 littermates. Data points in the main graph indicate median values for each tissue, except for e8.5 embryo for which only one biological sample was assayed, representing cDNA from pooled embryos; this value corresponds to the mean of three pipetting replicates. Data points in the inset graph represent mean values from three pipetting replicates performed for each sample.

The effects of loss of maternal germline methylation on *Herc3* poly(A) site use were assessed by qRT-PCR on e8.5 *Dnmt3L*^−/+^ embryos and wild-type littermates, using primers specific to *Nap1l5*, *Herc3a*, *Herc3c* and transcripts using the *Herc3b1* poly(A) site. *Nap1l5* abundance in the *Dnmt3L*^−/+^ sample is ∼2.1× that of the wild-type control ([Figure 3](#gks654-F3){ref-type="fig"}B), consistent with biallelic expression of this retrogene in the absence of promoter methylation on the maternally inherited chromosome. Additionally, expression of *Herc3c* increases by ∼1.7× in *Dnmt3L*^−/+^ embryos, providing further evidence that this transcript initiates from the differentially methylated promoter shared with *Nap1l5*.

Both *Herc3a* and *Herc3b* transcripts demonstrate an increase in abundance in *Dnmt3L*^−/+^ embryos. *Herc3b* transcripts are ∼3.5× more abundant in mutant embryos, compared with a modest increase in *Herc3a* abundance of ∼1.2×. In the case of *H13*/*Mcts2*, the increase in the use of upstream *H13* poly(A) sites in *Dnmt3L*^−/+^ embryos is correlated with a reduction in expression of the full-length *H13a* form ([@gks654-B8]). This result is replicated in the present study, in which full-length *H13a* transcripts are reduced by ∼60% in *Dnmt3L*^−/+^ embryos ([Figure 3](#gks654-F3){ref-type="fig"}B). The modest increase in the abundance of full-length *Herc3a* transcripts may be a consequence of a change in expression of a transcriptional regulator resulting from ablation of maternal germline methylation. However, given that both *Herc3a* and *Herc3b* initiate at the same promoter, the change in the *Herc3a*:*Herc3b* ratio between wild-type and *Dnmt3L*^−/+^ embryos reflects the use of alternative polyadenylation sites. Thus, allele-specific methylation at the *Nap1l5* promoter influences *Herc3* poly(A) site choice.

*Herc3b* and *Nap1l5* expression levels are correlated, suggesting a role for transcriptional interference
----------------------------------------------------------------------------------------------------------

Having established a role for DNA methylation in the regulation of alternative polyadenylation at the *Herc3* locus, as well as at the *H13* locus previously ([@gks654-B8]), we considered the mechanisms that could be responsible for effecting this regulation. It is interesting, and likely informative, that the use of alternative poly(A) sites at *Herc3* is coupled to alternative splicing ([Figure 1](#gks654-F1){ref-type="fig"}A and [Supplementary Figure 1](http://nar.oxfordjournals.org/cgi/content/full/gks654/DC1)). Internal poly(A) sites are utilized exclusively with the incorporation of exons 23b or 23c into mature transcripts. The allele-specific inclusion of these exons may reflect differences in the activity of the transcription elongation complex on the two alleles. We reasoned that, ultimately, these differences in splicing and poly(A) site use could be caused by at least two mechanisms. The first is transcriptional interference resulting from retrogene transcription; and the second is through the binding of a methylation-sensitive polyadenylation factor at the gDMR. Transcriptional interference describes the direct negative impact of one transcriptional activity on a second transcriptional activity *in cis* ([@gks654-B25]). In the case of *Nap1l5*/*Herc3*, it is possible that the progression of the transcription elongation complex along the *Nap1l5* gene body, or the accumulation of poised RNA polymerase II at the *Nap1l5* promoter, may interfere with transcriptional elongation of *Herc3*.

*Nap1l5* is most abundantly expressed in brain, with lower levels of expression observed in heart and lung ([Figure 3](#gks654-F3){ref-type="fig"}C) ([@gks654-B15],[@gks654-B26]). We hypothesized that if transcriptional interference from *Nap1l5* is responsible for internal *Herc3* polyadenylation, *Herc3b* abundance would also be greatest in brain compared with heart and lung. Using qRT-PCR, we demonstrate that *Herc3b* is indeed most abundant in newborn brain, where *Nap1l5* transcription is greatest, and is considerably reduced in heart and lung ([Figure 3](#gks654-F3){ref-type="fig"}D). This correlation between *Nap1l5* and *Herc3b* cannot be attributed to an overall increase in transcription at the locus in brain, because levels of *Herc3a* do not follow this trend, being more abundant in heart than brain ([Figure 3](#gks654-F3){ref-type="fig"}E). Tissue-specific differences in *Nap1l5* expression between brain, heart, lung and wild-type e8.5 embryo show a positive correlation with the abundance of *Herc3b* transcripts ([Figure 3](#gks654-F3){ref-type="fig"}F). Further, we show that the natural variation in *Nap1l5* expression observed in brains isolated from wild-type littermates also positively correlates with *Herc3b* abundance ([Figure 3](#gks654-F3){ref-type="fig"}F, inset). Although *Herc3a* and *Herc3b* transcripts initiate from the same promoter, the tissue-specific differences in *Herc3b* abundance are more reflective of *Nap1l5* expression levels than of *Herc3a*.

The bias toward the expression of full-length *Herc3a* transcripts from the maternally derived allele, established earlier using Sanger sequencing and pyrosequencing, could be explained by the paternal allele-specific expression of *Nap1l5*, which might interfere with *Herc3* transcriptional elongation. If this model of transcriptional interference is correct, lower levels of *Nap1l5* transcription in heart and lung should correlate with a shift towards more equal *Herc3a* expression from both parental alleles. This prediction holds true, with biallelic *Herc3a* expression observed in both of these tissues using Sanger sequencing ([Figure 2](#gks654-F2){ref-type="fig"}C). We confirmed this with a quantitative assessment in heart using pyrosequencing, which demonstrated an approximately 52:48 maternal:paternal ratio in both the B × C and C × B reciprocal intercrosses ([Figure 2](#gks654-F2){ref-type="fig"}B).

DISCUSSION
==========

The association between epigenetics and polyadenylation is an emerging topic with recent studies demonstrating that globally, at least in humans, poly(A) sites are depleted for nucleosomes and most post-translational histone marks, but are enriched for H3K9me3 ([@gks654-B27],[@gks654-B28]). However, the importance of epigenetic marks in regulating alternative polyadenylation remains largely unexplored, in contrast to relatively abundant evidence for epigenetic control of alternative promoter choice and, more recently, of alternative splicing. Previously, we demonstrated a role for DNA methylation in the control of alternative polyadenylation at the *H13* locus ([@gks654-B8]). Methylation at the promoter of an intronic retrogene, *Mcts2*, is specific to the maternal allele, causing *Mcts2* to be imprinted. On the paternal allele, from which *Mcts2* is expressed, *H13* transcripts utilize upstream poly(A) sites. Whether this occurs due to retrogene-mediated transcriptional interference, or, alternatively, due to methylation-sensitive binding of a polyadenylation factor that is unrelated to retrogene transcription, has not been determined.

Intronic positioning within a multi-exonic gene is a common feature of several imprinted retrogenes ([@gks654-B9],[@gks654-B29]). This is also true of retrogenes present in human but absent in mouse, such as the imprinted retrogene at the *RB1* locus ([@gks654-B30]). Additionally, the imprinted human retrogene *FAM50B* probably lies in an intron of a non-coding RNA (BG721636) ([@gks654-B31],[@gks654-B32]). That several imprinted retrogenes are intronic may reflect a requirement for transcription through gDMRs during maternal germline methylation establishment ([@gks654-B24],[@gks654-B33]).

In this study, we show that the relationship between *Mcts2* and *H13* is not unique to that locus, but is also observed for the intronic retrogene *Nap1l5* and its host *Herc3* ([Figure 4](#gks654-F4){ref-type="fig"}A). Loss of differential methylation on the parental alleles at the *Nap1l5* promoter causes a change in the ratio of *Herc3* transcripts using upstream and downstream poly(A) sites, demonstrating a role for epigenetic marks in regulating alternative polyadenylation. The allele-specific utilization of an internal *Herc3* poly(A) site positively correlates with levels of *Nap1l5* expression in different tissues, and between brain samples of wild-type littermates, but does not correlate with expression of full-length *Herc3a*, despite *Herc3a* and *Herc3b* initiating at the same promoter. Biallelic expression of *Nap1l5* in *Dnmt3L*^−/+^ embryos also correlates with increased use of this internal poly(A) site. Further, in brain---the tissue in which *Nap1l5* is most abundantly expressed---full-length *Herc3a* transcripts are expressed with a bias from the maternal allele on which *Nap1l5* is silenced. In tissues where *Nap1l5* expression is relatively low, *Herc3a* transcription is biallelic. These data support the hypothesis that polyadenylation can be regulated by transcriptional interference, although still cannot fully exclude the involvement of a methylation-sensitive polyadenylation factor that may demonstrate tissue-specific differences in activity. The coupling of alternative polyadenylation to the incorporation of alternative exons in *Herc3* transcripts suggests that differences in the activity of transcription elongation complexes between the two alleles may form part of the mechanism. For example, the inclusion of weak alternative exons can reflect slow progress of an elongation complex ([@gks654-B34]). Our ongoing work is addressing the molecular mechanism by which methylation controls alternative polyadenylation. Figure 4.Allele-specific alternative poly(A) at the *Herc3*/*Nap1l5* locus in brain and putative proteins encoded by *Herc3* transcripts. (**A**) In brain, *Herc3a* is predominantly expressed from the maternally inherited chromosome (mat) with a smaller contribution (illustrated by a dashed line) from the paternally derived copy (pat). The *Nap1l5* promoter is methylated (filled lollipops) on the maternal allele and hypomethylated (open lollipops) on the paternal copy, from which *Nap1l5* is expressed. The *Nap1l5* promoter is likely to be a bidirectional promoter, permitting expression of *Herc3c* from the paternal allele. Upstream poly(A) sites are utilized by a subset of *Herc3* transcripts on the paternal allele, producing *Herc3b*. Poly(A) sites are indicated by *A*~n~. (**B**) Alignment of the predicted proteins encoded by *Herc3a*, *Herc3b* and *Herc3c* transcripts. Only *Herc3a* would encode a complete HECT domain (black box), important for Herc3 function as an E3 ubiquitin ligase. The N and C termini are indicated.

By northern blotting we found that, in brain, processed *Herc3a* transcripts represent 98% of transcripts initiating at the shared *Herc3a*/*Herc3b* promoter. Despite this, full-length *Herc3a* transcripts still exhibit biased expression from the maternal allele, suggesting that the internal poly(A) sites may be used by more than 2% of transcripts on the paternal allele. Many of the *Herc3b* transcripts may be degraded before processing, explaining their relatively low abundance as detected by northern blotting. Some of the contribution to *Herc3a* transcripts from the paternal allele may reflect cell type-specific imprinting, dependent on *Nap1l5* expression. For example, *Herc3* is abundantly expressed in the piriform cortex relative to expression of *Nap1l5* ([@gks654-B26]), and this may enable biallelic expression of full-length *Herc3a* transcripts in these cells. However, *Herc3* and *H13* exhibit both maternally and paternally expressed transcripts within the same cell type. The difference between transcripts derived from the two parental alleles is the use of poly(A) sites. This is different to the imprinted gene *Grb10*, which gives rise to both maternal and paternal allele-specific transcripts but these are expressed in distinct cell types where they perform discrete functions ([@gks654-B35],[@gks654-B36]). *Grb10* transcripts differ in their use of promoters, but not poly(A) sites.

Human HERC3, like other HERC family members, contains a domain homologous to E6 associated protein carboxy-terminus (HECT) \[reviewed in ([@gks654-B37])\]. Functional assays identify HERC3 as a probable E3 ubiquitin ligase that targets proteins for proteasomal-mediated degradation through its HECT domain, and co-localizes with proteins involved with intracellular transport ([@gks654-B11]). Murine Herc3 also contains a predicted HECT domain ([Figure 4](#gks654-F4){ref-type="fig"}B). While *Herc3b* and *Herc3c* contain ORFs, only the *Herc3a* transcript would encode a full-length HECT domain necessary for ubiquitin ligase activity. Thus, the *Herc3b* and *Herc3c* transcripts may not be of direct biological importance, and this may explain the likely degradation of *Herc3b* transcripts discussed above. Further functional analyses are required to examine the roles of any peptides produced from these transcripts.

Recently, alternative polyadenylation of the imprinted gene *Mest* has been shown to influence imprinted expression of a neighboring gene ([@gks654-B38]). In this system, alternative polyadenylation produces an extended transcript of *Mest*, called *MestXL*, in the central nervous system. *MestXL* is expressed from the paternally inherited chromosome and transcribes into the downstream anti-sense gene *Copg2*. *Copg2* is imprinted exclusively in the central nervous system and is expressed from the maternally inherited chromosome. Experimental truncation of *MestXL* causes loss of imprinting of *Copg2*, indicating that tissue-specific alternative polyadenylation regulates *Copg2* imprinting probably by transcriptional interference. This is different to the situation with *Herc3*/*Nap1l5* and *H13*/*Mcts2*, in which imprinted retrogene expression controls alternative polyadenylation of the host. Together, these studies illustrate the intimate, allele-specific relationships between neighboring transcripts.

We have shown, in this and a previous study, that transcript poly(A) site choice can be regulated by DNA methylation at internal CGIs. Allele-specific histone modifications are also likely to be important in this system as we have previously shown enrichment at *Nap1l5* and *Mcts2* of active and repressive modifications on the paternally and maternally inherited copies, respectively ([@gks654-B39]). Our work on elucidating the mechanism through which DNA methylation controls alternative polyadenylation at imprinted retrogene loci will explore the importance of other epigenetic marks.

While the relationship between *Herc3* and *Nap1l5*, as well as *H13* and *Mcts2*, is complicated by the imprinted nature of the retrogenes, the intimate host/retrogene relationship may not be limited to imprinted loci. Indeed, a similar situation has recently been reported at sites of mouse endogenous retrovirus (ERV) integration, where an intronic insertion can cause upstream transcriptional termination ([@gks654-B40]). In at least one case, an intronic ERV promoter exhibits variable methylation between individuals ([@gks654-B41]). When the promoter is unmethylated, the ERV is expressed and the host gene utilizes upstream poly(A) sites. However, there is no evidence for imprinting at this locus and poly(A) sites are utilized differently between individuals. Using global approaches, it will be important to evaluate the extent to which retrogenes and retrotransposons influence poly(A) site choice.
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